Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Intel Honored by Frost & Sullivan for Developing Its Intel® Health Application Platform for Remote Health Usage Models

Frost & Sullivan
Posted on: 18 Jul 18
Intel Honored by Frost & Sullivan for Developing Its Intel® Health Application Platform for Remote Health Usage Models The platform can potentially expand the number and scale of remote patient monitoring (RPM) implementations and ultimately improve care delivery at a lower total cost of ownership for providers

PR Newswire

SANTA CLARA, Calif., July 18, 2018

SANTA CLARA, Calif., July 18, 2018 /PRNewswire/ -- Based on its recent analysis of the North American remote patient monitoring (RPM) market, Frost & Sullivan recognizes Intel with the 2018 North American New Product Innovation Award for the Intel Health Application Platform (HAP), an innovative application software platform that can be used by remote care solution providers to enable a variety of remote health usage models. To make the Intel HAP platform readily available to solution providers, Intel has collaborated with Flex – the Sketch-to-Scale™ solutions provider that designs and builds Intelligent Products for a Connected World™.  The Flex IoT Compute Engine based on the optimized Intel architecture hardware design specification coupled with the Intel HAP software provides an innovative solution which reduces hospital readmissions, lowers costs, and accelerates time to market.

Click here to view the multimedia release: http://best-practices.frost-multimedia-wire.com/intel-hap

"The Intel Health Application Platform software coupled with the Flex IoT Compute Engine is designed to help the ecosystem of RPM solution providers develop a variety of new and exciting usage models to accelerate remote care," said Victor Camlek, Principal Industry Analyst.  "This solution helps address a range of immediate needs including reducing potential provider penalties for readmission and enhancing care for aging populations and people with one or more chronic diseases."

Some of the outstanding benefits of this product include:

  • Stable software environment that eliminates disruptive system updates
  • True data ownership as the data is encrypted and stored until it can be forwarded to the back-end location designated by the solution owner (Intel does not own patient and other medical data)
  • Advanced security methodologies to help protect trusted data
  • Growing number of verified peripherals
  • Support for Continua and Bluetooth Low Energy compliant peripherals
  • Highly customizable solution with powerful features and low R&D
  • Flexible app development (Intel enables solution providers to layer their own or relevant Android-based, value-added apps)
  • Offers hardware, software, and communications services, as well as logistics, through global ecosystem partner, Flex.

Initial use cases include RPM, assisted living monitoring, chronic disease management, post-acute care management, and clinical drug and therapy trials. Given the demanding requirements of these use cases, Intel HAP offers enterprise-grade stability, security, and longevity which are critical needs in this market.  In addition, remote care use cases enabled by Intel HAP provide new, rich data streams to feed the growing number of AI and analytics applications that health care providers need for better diagnosis and treatment.

"Intel® HAP coupled with the Flex IoT Compute Engine can dramatically simplify the collection and sharing of RPM information, saving money for providers while uncovering new monitoring scenarios. Intel is also creating an ecosystem of medical-grade remote care service providers to boost reliability," noted Camlek. "The opportunity to transform the robust stream of RPM-generated data to intelligence is important, and Intel has positioned itself as a valuable technology partner to healthcare industry participants."

Each year, Frost & Sullivan presents this award to the company that has developed an innovative element in a product by leveraging leading-edge technologies. The award recognizes the value-added features/benefits of the product and the increased return on investment (ROI) it gives customers, which, in turn, raises customer acquisition and overall market penetration potential.

Frost & Sullivan Best Practices awards recognize companies in a variety of regional and global markets for demonstrating outstanding achievement and superior performance in areas such as leadership, technological innovation, customer service, and strategic product development. Industry analysts compare market participants and measure performance through in-depth interviews, analysis, and extensive secondary research to identify best practices in the industry.

About Frost & Sullivan

Frost & Sullivan, the Growth Partnership Company, works in collaboration with clients to leverage visionary innovation that addresses the global challenges and related growth opportunities that will make or break today's market participants. For more than 50 years, we have been developing growth strategies for the global 1000, emerging businesses, the public sector, and the investment community. Contact us: Start the discussion.

Contact:

Samantha Park
P: 210.247.2426
F: 210.348.1003
E: samantha.park@frost.com

 

View original content:http://www.prnewswire.com/news-releases/intel-honored-by-frost--sullivan-for-developing-its-intel-health-application-platform-for-remote-health-usage-models-300682785.html

SOURCE Frost & Sullivan

PR Newswire
www.prnewswire.com

Last updated on: 18/07/2018

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.